NCT01089868View on ClinicalTrials.gov

Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2012

Conditions
Glioblastoma Multiforme
Trial Locations (3)

53127

University Hospital Bonn, Department of Neurosurgery, Bonn

79095

Department of Stereotactic Neurosurgery, Freiburg im Breisgau

81377

University Hospital Munich, Department of Neurosurgery, Munich

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

lead

Ludwig-Maximilians - University of Munich

OTHER

NCT01089868 - Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients | Biotech Hunter | Biotech Hunter